Research Pipeline

Lilly currently has an unprecedented number of molecules in clinical development. The company is generating potential biotech solutions alongside more traditional chemistry-based work in order to deliver innovative treatments to patients for a wide range of diseases, including cancer, diabetes, osteoporosis, rheumatoid arthritis and Alzheimer's disease.
One of Lilly's most promising areas of research and development concerns personalized medicine, more broadly defined as tailored therapies. The ultimate goal is to provide improved outcomes for individual patients.